Stay updated with breaking news from Gesynta Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted Orphan Drug Designation to belimumab, a B-cell inhibiting monoclonal antibody, for the potential treatment of systemic sclerosis, according to a press release from GlaxoSmithKline.
/PRNewswire/ -- Good tailwind in the financial development Q2 2022 highlights Total net revenues of SEK 147.8 m (142.8) EBITDA of SEK -32.5 m (-41.1) Net...
UPPSALA, Sweden, April 28, 2022 /PRNewswire/ -- Promising start to 2022 Q1 2022 highlights Total net revenues of SEK 159.4 m (132.3) EBITDA of SEK 2.8 m (-23.9)
/PRNewswire/ -- Promising start to 2022 Q1 2022 highlights Total net revenues of SEK 159.4 m (132.3) EBITDA of SEK 2.8 m (-23.9) Net earnings of SEK -23.6 m...
/PRNewswire/ -- Promising start to 2022 Q1 2022 highlights Total net revenues of SEK 159.4 m (132.3) EBITDA of SEK 2.8 m (-23.9) Net earnings of SEK -23.6 m...